Claus Juan Møller-San Pedro
Profile
Claus Juan Møller-San Pedro was the founder of I.
P.
Cons ApS (1994) and Azanta A (1994), where he held the titles of Chief Executive Officer and Managing Director, respectively.
He is currently a Director at Terranol A. Dr. Møller-San Pedro's former positions include Director at EpiTherapeutics ApS, Medical Director at Synthélabo Scandinavia A, Director, Chief Executive & Commercial Officer at Y-mAbs Therapeutics, Inc., Executive VP, Chief Operating & Medical Officer at Oncotelic Therapeutics, Inc., Chief Operating Officer & Executive Vice President at Genmab A, and President at IPC Corp.
Ltd. Dr. Møller-San Pedro holds a doctorate degree from the University of Copenhagen.
Claus Juan Møller-San Pedro active positions
| Companies | Position | Start |
|---|---|---|
Terranol A/S
Terranol A/S Miscellaneous Commercial ServicesCommercial Services Provides yeasts for bioethanol production | Director/Board Member | 08/07/2009 |
Former positions of Claus Juan Møller-San Pedro
| Companies | Position | End |
|---|---|---|
| YMAS THER | Chief Executive Officer | 22/04/2022 |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Chief Executive Officer | 01/01/2015 |
| GENMAB A/S | Chief Operating Officer | 01/01/2008 |
I. P. Cons ApS
I. P. Cons ApS Real Estate DevelopmentFinance Leases property and equipment; and provides investment services | Chief Executive Officer | - |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology Develops novel cancer drugs based on epigenetics | Director/Board Member | - |
Training of Claus Juan Møller-San Pedro
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Oncotelic Therapeutics, Inc.
Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Genmab A/S
Genmab A/S Pharmaceuticals: MajorHealth Technology Develops differentiated antibody therapeutics for treatment of cancer | Health Technology |
IPC Corp. Ltd.
IPC Corp. Ltd. Hotels/Resorts/Cruise linesConsumer Services Operates as an investment holding company with interest in providing hotel management and property selling services | Consumer Services |
I. P. Cons ApS
I. P. Cons ApS Real Estate DevelopmentFinance Leases property and equipment; and provides investment services | Finance |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terranol A/S
Terranol A/S Miscellaneous Commercial ServicesCommercial Services Provides yeasts for bioethanol production | Commercial Services |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology Develops novel cancer drugs based on epigenetics | Health Technology |
Synthélabo Scandinavia A/S | |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Health Technology |
Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. Develops novel antibody therapeutics for oncology targets |
- Stock Market
- Insiders
- Claus Juan Møller-San Pedro
















